TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11971667

Group type: EXPERIMENTAL
Intervention: Glucose (n = 8)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Protein (n = 10)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Fat (n = 10)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Water (n = 9)
Number of subjects: 37
Study: 10188139

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgical treatment (uvulopalatopharyngoplasty with or without mandibular osteotomy)
Number of subjects: 50
Study: 7751690

Group type: EXPERIMENTAL
Intervention: Alternating zidovudine and didanosine therapy
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Simultaneous zidovudine and didanosine therapy
Number of subjects: 26
Study: 2260198

Group type: EXPERIMENTAL
Intervention: Sorghum-based oral rehydration solution (ORS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: WHO recommended ORS
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sorghum-based ORS
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 6805243

Group type: EXPERIMENTAL
Intervention: 20/250 combination of ethinylestradiol and levonorgestrel
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 30/250 combination of ethinylestradiol and levonorgestrel
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 30/150 combination of ethinylestradiol and levonorgestrel
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Triphasic drug combination of ethinylestradiol and levonorgestrel
Number of subjects: 98
Study: 31279326

Group type: EXPERIMENTAL
Intervention: TVS inserted percutaneously with fluoroscopy
Number of subjects: 96

Group type: COMPARATOR
Intervention: TVS inserted percutaneously without fluoroscopy
Number of subjects: 96
Study: 30650499

Group type: EXPERIMENTAL
Intervention: Compound Xuanju Capsule (CXC)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 25751829

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery without OVD
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard phacoemulsification with OVD
Number of subjects: 37
Study: 23880826

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy (CFRT) with 64 Gy and a 1.0- or 1.5-cm margin
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy (CFRT) with a ±10 Gy boost to the prostate alone
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy (CFRT)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Dose escalation
Number of subjects: 126
Study: 21844495

Group type: EXPERIMENTAL
Intervention: Carboplatin plus pegylated liposomal doxorubicin (PLD) 30 mg/m²
Number of subjects: 820

Group type: COMPARATOR
Intervention: Carboplatin plus paclitaxel 175 mg/m²
Number of subjects: 820
Study: 19659999

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg day(-1) for 12 weeks)
Number of subjects: 199
Study: 20880431

Group type: EXPERIMENTAL
Intervention: Capnometry
Number of subjects: 63

Group type: COMPARATOR
Intervention: Pulse Oximetry
Number of subjects: 63
Study: 16274596

Group type: EXPERIMENTAL
Intervention: rFSH + HMG
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: rFSH + rLH
Number of subjects: 94
Study: 12145173

Group type: EXPERIMENTAL
Intervention: L-NMMA (6 mg/kg total dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9927359

Group type: EXPERIMENTAL
Intervention: Rifampin-monoresistant tuberculosis (RMR-TB) patients
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Rifampin-monoresistant tuberculosis (RMR-TB) patients with a history of TB
Number of subjects: 69
Study: 7473124

Group type: EXPERIMENTAL
Intervention: Heparin surface modified (HSM) IOL
Number of subjects: 54

Group type: COMPARATOR
Intervention: Poly(methyl methacrylate) (PMMA) IOL
Number of subjects: 54
Study: 2176815

Group type: EXPERIMENTAL
Intervention: 40 ml 1.4% mepivacaine with epinephrine (1:200,000) and 4 mEq of NaHCO3
Number of subjects: 40

Group type: COMPARATOR
Intervention: 40 ml 1.4% mepivacaine with epinephrine (1:200,000)
Number of subjects: 40
Study: 7467378

Group type: EXPERIMENTAL
Intervention: K. H. 3 (medication)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 30507225

Group type: EXPERIMENTAL
Intervention: Associative No‐Go ICT
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Associative Stop Signal ICT
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: General Inhibition ICT
Number of subjects: 246

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 246
Study: 27083066

Group type: EXPERIMENTAL
Intervention: SCMMF dissection in 30 (23.1%) patients
Number of subjects: 130

Group type: COMPARATOR
Intervention: Non-SCMMF group
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Follow-up examinations at 6, 12, and 24 months
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Overall patient feedback after 2 years
Number of subjects: 130
Study: 24929796

Group type: EXPERIMENTAL
Intervention: Epoprostenol at 1 ng/kg/min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Epoprostenol at 2 ng/kg/min
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 22122289

Group type: EXPERIMENTAL
Intervention: Healthy Weight group-based 4-hr prevention program
Number of subjects: 398

Group type: COMPARATOR
Intervention: Educational brochure control condition
Number of subjects: 398
Study: 20150289

Group type: EXPERIMENTAL
Intervention: Multifrequency bioelectrical impedance (BI) method for estimating visceral fat area (VFA)
Number of subjects: 103
Study: 18762589

Group type: EXPERIMENTAL
Intervention: Paternal age 55 years and older
Number of subjects: 13428

Group type: EXPERIMENTAL
Intervention: Paternal age <20 years (early-onset cases)
Number of subjects: 13428

Group type: COMPARATOR
Intervention: Paternal age 20 to 24 years (reference group)
Number of subjects: 13428
Study: 16391447

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 12450887

Group type: EXPERIMENTAL
Intervention: Diacylglycerol oil
Number of subjects: 131

Group type: COMPARATOR
Intervention: Triacylglycerol oil
Number of subjects: 131
Study: 10624640

Group type: COMPARATOR
Intervention: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% without epinephrine (pH = 6.3)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% with 8.4% sodium bicarbonate (mean final pH = 6.90)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% with 8.4% sodium bicarbonate (mean final pH = 7.16)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% with 8.4% sodium bicarbonate (mean final pH = 7.43)
Number of subjects: 144
Study: 8835616

Group type: EXPERIMENTAL
Intervention: Ketamine (80 micrograms/kg/s.c.)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ketamine (80 micrograms/kg/s.c., three times a day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Saline (0.9% NaCl)
Number of subjects: 34
Study: 2109497

Group type: EXPERIMENTAL
Intervention: Antidepressant with predominant serotoninergic action (indalpine or citalopram)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Noradrenergic antidepressant (maprotiline)
Number of subjects: 100

Group type: COMPARATOR
Intervention: TRH test
Number of subjects: 100
Study: 7438751

Group type: EXPERIMENTAL
Intervention: Reversible tubal sterilization
Number of subjects: 1074
Study: 31291314

Group type: EXPERIMENTAL
Intervention: Intervention group with access to different bike types (e-bike with trailer, cargo bike, traditional bike with trailer)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 36
Study: 29323626

Group type: EXPERIMENTAL
Intervention: CBT-based mobile-app program (Todac Todac)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Daily mood chart app program (control group)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups (TT group and control group)
Number of subjects: 34
Study: 27454011

Group type: EXPERIMENTAL
Intervention: Recall manipulation of preoccupying secrets
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Recall manipulation of extreme exemplar secrets
Number of subjects: 3000
Study: 25019632

Group type: EXPERIMENTAL
Intervention: Telerehabilitation (Tele)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional therapy (Conv)
Number of subjects: 24
Study: 22670591

Group type: EXPERIMENTAL
Intervention: Conventional HUT (20-minute passive tilt followed by 25 minutes after administration of sublingual isosorbide dinitrate)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Shortened HUT (ISDN given immediately after tilt and observed for 25 minutes)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (age- and gender-matched subjects without VVS symptoms)
Number of subjects: 60
Study: 20633872

Group type: EXPERIMENTAL
Intervention: Minimal endometriosis group
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (women without endometriosis)
Number of subjects: 300
Study: 18336919

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) - 5 sessions
Number of subjects: 20
Study: 16150195

Group type: EXPERIMENTAL
Intervention: Yigu capsule (YGC)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210

Group type: COMPARATOR
Intervention: Calciferol
Number of subjects: 210
Study: 11124354

Group type: EXPERIMENTAL
Intervention: Non-word primes differing by a single phonemic feature (e.g. ZEA, VILM, PASIC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-word primes differing by more than a single phonemic feature (e.g. VEA, JILM, SASIC)
Number of subjects: 0
Study: 9849010

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT) alone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Concurrent chemo-radiotherapy (CT + RT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 39
Study: 8010424

Group type: EXPERIMENTAL
Intervention: Interactive learning system with 'sensorized' manikin head
Number of subjects: 97

Group type: COMPARATOR
Intervention: Didactic instruction from anesthesiologists
Number of subjects: 97
Study: 2589071

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 20

Group type: COMPARATOR
Intervention: Injected anaesthetic
Number of subjects: 20
Study: 1059213

Group type: EXPERIMENTAL
Intervention: Male subjects with male audience
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Male subjects with female audience
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Female subjects with male audience
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Female subjects with female audience
Number of subjects: 48
Study: 31377711

Group type: EXPERIMENTAL
Intervention: Group Appointments in Primary Care (GAP) intervention
Number of subjects: 15
Study: 28139220

Group type: EXPERIMENTAL
Intervention: Drug-Eluting Balloons (DEB) for DES-ISR
Number of subjects: 249

Group type: COMPARATOR
Intervention: Drug-Eluting Balloons (DEB) for BMS-ISR
Number of subjects: 249
Study: 26119968

Group type: COMPARATOR
Intervention: Accumulated million steps group (AMSG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Aerobic exercise group (AEG)
Number of subjects: 120
Study: 23557553

Group type: EXPERIMENTAL
Intervention: Double kissing (DK) crush technique
Number of subjects: 61

Group type: COMPARATOR
Intervention: Classical crush technique
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Post-procedural minimum stent area (MSA)
Number of subjects: 61
Study: 21682869

Group type: EXPERIMENTAL
Intervention: Organized exercise training three times per week starting in gestation week 14 (range 12‐16)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 150
Study: 20092180

Group type: EXPERIMENTAL
Intervention: Surgery preceded by studying haemostasiograms, biochemical parameters, indices of the functional system of detoxication, level of acute-phase proteins, cytokines, stress enzymes.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 34
Study: 16629894

Group type: EXPERIMENTAL
Intervention: 0.5% sodium hypochlorite (NaOCl)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Enzymatic commercial solution (Ortoform)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 13
Study: 14769738

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (50 mg/d)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (20 mg/d)
Number of subjects: 29133

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 29133
Study: 11411816

Group type: EXPERIMENTAL
Intervention: Ziprasidone treatment
Number of subjects: 37
Study: 9582179

Group type: EXPERIMENTAL
Intervention: NeuroSPECT findings in anosmic patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 18
Study: 7996624

Group type: EXPERIMENTAL
Intervention: Rinne test (unmasked and masked)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Weber test
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Bing test
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Rinne test (without masking)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Normal hearing (control group)
Number of subjects: 68
Study: 3255892

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study: 31888751

Group type: EXPERIMENTAL
Intervention: Lumen-apposing metal stents (LAMS)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Plastic stents
Number of subjects: 114
Study: 28954841

Group type: EXPERIMENTAL
Intervention: Iron-biofortified beans (86.1 ppm iron)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control beans (50.1 ppm iron)
Number of subjects: 150
Study: 26122296

Group type: EXPERIMENTAL
Intervention: Monophasic OC users
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: NC women
Number of subjects: 377

Group type: COMPARATOR
Intervention: Men
Number of subjects: 377

Group type: COMPARATOR
Intervention: OC users (heterogeneous group)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol levels in OC users
Number of subjects: 377
Study: 23548260

Group type: EXPERIMENTAL
Intervention: Solifenacin succinate (SS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 40
Study: 22032052

Group type: EXPERIMENTAL
Intervention: DDDR pacing mode
Number of subjects: 67

Group type: COMPARATOR
Intervention: WIR pacing mode
Number of subjects: 67
Study: 18293201

Group type: EXPERIMENTAL
Intervention: MgSO(4) continuous infusion for 24 hours postpartum (Group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: MgSO(4) administration discontinued when urinary output was > or =100 ml/hr for 2 consecutive hours (Group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study: 17069813

Group type: EXPERIMENTAL
Intervention: Laparoscopic proximal tubal occlusion
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Laparoscopic salpingectomy
Number of subjects: 115

Group type: COMPARATOR
Intervention: No surgical intervention
Number of subjects: 115
Study: 12233987

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 2
Study: 10194084

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 9

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 9
Study: 7761293

Group type: EXPERIMENTAL
Intervention: ComputerLink
Number of subjects: 102
Study: 2405896

Group type: EXPERIMENTAL
Intervention: Flumazenil i.v. and placebo s.c. (group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flumazenil i.v. and flumazenil s.c. (group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo i.v. and placebo s.c. (control group)
Number of subjects: 30
Study: 7415857

Group type: EXPERIMENTAL
Intervention: Percutaneous femoral artery catheterization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 6342959

Group type: EXPERIMENTAL
Intervention: Metronidazole suppositories (short-term use for 72 hours)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 31238713

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Any previous peripheral revascularization
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Baseline atrial fibrillation
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Baseline ankle-brachial index =0.60
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Baseline statin use
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: ALI hospitalization
Number of subjects: 13885
Study: 28952862

Group type: EXPERIMENTAL
Intervention: 4-week, 12-session feedback intervention including self-analysis and expert feedback on jump-landing mechanics
Number of subjects: 0
Study: 26833642

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2737

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2737
Study: 25191896

Group type: EXPERIMENTAL
Intervention: Intact whey protein (IW)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hydrolysed casein (HC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intact casein (IC)
Number of subjects: 24
Study: 22834921

Group type: EXPERIMENTAL
Intervention: Methadone and ketamine (MK)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Methadone alone (ME)
Number of subjects: 22
Study: 21164546

Group type: EXPERIMENTAL
Intervention: β‐glucan (100 mg, Imunoglukan) supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 20
Study: 17825546

Group type: EXPERIMENTAL
Intervention: Omega-3 and omega-6 polyunsaturated fatty acids (PUFA) supplementation
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (palm oil)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both PUFA and placebo groups
Number of subjects: 104
Study: 16126134

Group type: EXPERIMENTAL
Intervention: Tissue plasminogen activator
Number of subjects: 624

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 624
Study: 12269944

Group type: EXPERIMENTAL
Intervention: Skin prick testing (SPT) and food-specific IgE assessment for potential cross-reactive foods
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Routine challenges with potential cross-reactive foods
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SPT and food-specific IgE levels for potential cross-reactive foods
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Elimination diets based on allergy testing
Number of subjects: 65
Study: 10024253

Group type: EXPERIMENTAL
Intervention: Pelvic floor exercises (n=25)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (n=25)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Vaginal cones (n=27)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 107
Study: 7845115

Group type: EXPERIMENTAL
Intervention: Single course of portal infusion with mitomycin (10 mg/m2, one dose) plus fluorouracil (500 mg/m2 per 24 h for 7 days)
Number of subjects: 533

Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 533
Study: 2140842

Group type: EXPERIMENTAL
Intervention: Bright white light therapy (2500 lux)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dim light therapy (50 lux)
Number of subjects: 30
Study: 572195

Group type: EXPERIMENTAL
Intervention: Piloplex (11 b.i.d.)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Pilocarpine hydrochloride 2% q.i.d.
Number of subjects: 51
Study: 30572281

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided platelet-rich plasma (PRP) injection
Number of subjects: 36

Group type: COMPARATOR
Intervention: Platelet-poor plasma (PPP) injection
Number of subjects: 36
Study: 27878381

Group type: EXPERIMENTAL
Intervention: S-ICD®
Number of subjects: 120

Group type: COMPARATOR
Intervention: tv-ICD
Number of subjects: 120
Study: 25894865

Group type: EXPERIMENTAL
Intervention: Selenomethionine (SeMet) 200 μg daily (n = 28)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (n = 27)
Number of subjects: 55
Study: 23344509

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg per os divided in two doses (night before surgery and 1 h preoperatively)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg per os divided in two doses
Number of subjects: 50
Study: 21429799

Group type: EXPERIMENTAL
Intervention: Motesanib plus paclitaxel
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus paclitaxel
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Motesanib
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 282
Study: 19646212

Group type: EXPERIMENTAL
Intervention: MSP3-LSP candidate vaccine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tetanus toxoid vaccine (Control)
Number of subjects: 30
Study: 17376305

Group type: EXPERIMENTAL
Intervention: Combination therapy with terazosin 2 mg once daily and tolterodine 2 mg twice daily for 6 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Terazosin 2 mg once daily for 6 weeks
Number of subjects: 69
Study: 15264729

Group type: EXPERIMENTAL
Intervention: Crystalloid coload (20 ml x kg(‐1) of crystalloid solution by rapid infusion immediately after induction)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Crystalloid preload (20 ml x kg(‐1) of crystalloid solution during 20 minutes prior to induction)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Crystalloid preload and coload
Number of subjects: 50
Study: 12188588

Group type: EXPERIMENTAL
Intervention: Active bupropion
Number of subjects: 784

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 784
Study: 10786491

Group type: EXPERIMENTAL
Intervention: Automated Peritoneal Dialysis (APD) with large fill volumes and an extra daytime exchange
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional CAPD methods
Number of subjects: 0